Ep. 298 - Takeaways from the 25th Bio€quity Europe

Political and market turmoil has raised questions whether the U.S. can retain its biopharma leadership position, and in turn presents Europe with an opportunity to attract talent back to the continent with an offer of a more stable biomedical funding and regulatory environment. Jeito Capital’s Ksenija Pavletic and Cambridge Innovation Capital’s Anne Horgan join BioCentury’s analyst to wrap up the 25th annual Bio€quity Europe conference in Bruges, Belgium, by discussing their key takeaways from the two-day event. This episode was sponsored by Jeito Capital. View full story: https://www.biocentury.com/article/655998 #biotech #biopharma #pharma #lifescience #networking 00:01 - Sponsor Message: Jeito Capital 02:10 - Key Takeaways 09:13 - Challenges and Opportunities for Europe 19:23 - Capital Efficiency and Success Stories 28:27 - Leadership, Teams & Talent To submit a question to BioCentury’s editors, email the BioCentury This Week team at podcasts@biocentury.com. Reach us by sending a text